Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Castañon, E. (Eduardo) | - |
| dc.creator | Bosch-Barrera, J. (Joaquim) | - |
| dc.creator | Lopez, I. (Inés) | - |
| dc.creator | Collado, V. (Víctor) | - |
| dc.creator | Moreno, M. (Marta) | - |
| dc.creator | Lopez-Picazo, J.M. (José M.) | - |
| dc.creator | Arbea-Moreno, L. (Leire) | - |
| dc.creator | Lozano, M.D. (María Dolores) | - |
| dc.creator | Gil-Bazo, I. (Ignacio) | - |
| dc.date.accessioned | 2014-03-03T15:11:30Z | - |
| dc.date.available | 2014-03-03T15:11:30Z | - |
| dc.date.issued | 2013 | - |
| dc.identifier.citation | Castañon E, Bosch-Barrera J, López I, Collado V, Moreno M, López-Picazo JM et al. Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy. J Transl Med. 2013 Jan 11;11:13. | es_ES |
| dc.identifier.issn | 1479-5876 | - |
| dc.identifier.uri | https://hdl.handle.net/10171/35339 | - |
| dc.description.abstract | A correlation between Id1 and Id3 protein expression is observed. Id1 and Id3 co-expression seems associated with a poor clinical outcome in patients with locally advanced NSCLC treated with definitive chemoradiotherapy. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | BioMed Central | es_ES |
| dc.rights | info:eu-repo/semantics/openAccess | es_ES |
| dc.rights | info:eu-repo/semantics/openAccess | es_ES |
| dc.subject | Carcinoma, Non-Small-Cell Lung/drug therapy | es_ES |
| dc.subject | Combined Modality Therapy | es_ES |
| dc.subject | Carcinoma, Non-Small-Cell Lung/genetics | es_ES |
| dc.title | Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.
